Developed early in 2020 in response to the developing Covid-19 pandemic, Viral200 is a loose blend of our remedies for malaria (Demal200) and HIV (HIV200).
As with Demal200, Viral200 utilises potentised phosphorous to paralyse the ability of the virus to change its surface coating glycoprotein with which it mimics the blood in order to hide from the immune system.
Once visible it then stimulates the immune system to develop the correct T-Cell antibodies with which to seek out and attack the virus.
One bottle of Viral200 is sufficient to treat 2-3 cases of active Covid-19 or provide for ~4 months of prophylaxis protection against Covid-19.
If treating an active case of Covid-19 Viral200 will reduce the viral load and noticeably help improve respiratory function within 2-3 hrs of use.
If treated with Viral200, a recently diagnosed sufferer of Covid-19 should expect to be back to 80-90% of pre-Covid health within 48 hours.
Although a Covid-19 sufferer may recover from the acute phase without using Viral200, Viral200 will prevent the onset of Long Covid syndrome.
2-3 treatments of active Acute Covid-19 or;
~4 months protection against Covid-19